Literature DB >> 8473017

Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: no relevance to the development of experimental cerebral malaria.

P G Kremsner1, A Nüssler, S Neifer, M F Chaves, U Bienzle, G Senaldi, G E Grau.   

Abstract

The in vitro production of reactive nitrogen intermediates (RNI) by murine macrophages was evaluated in response to heat-stable malaria antigen and cytokines. Malaria antigen, interferon-gamma (IFN-gamma) and tumour necrosis factor (TNF) induced RNI production in macrophages in a dose-dependent way. RNI production steadily increased over a 2-day period and was enhanced when the malaria antigen was co-incubated with IFN-gamma and/or TNF. RNI production induced by either IFN-gamma or malaria antigen or a combination of the two was suppressed by pentoxifylline in a dose-dependent manner. Pentoxifylline did not significantly influence TNF-induced RNI production. L-N-monomethyl arginine reduced malaria antigen, IFN-gamma and TNF-induced RNI production when these reagents were used in combination or alone. An anti-TNF monoclonal antibody (mAb) reduced IFN-gamma-induced RNI production, but did not significantly alter the malaria antigen-induced RNI synthesis by macrophages. The influence of inhibitors of nitric oxide synthase, L-N-monomethyl arginine and N omega-nitro-L-arginine, was studied in experimental cerebral malaria. They did not exert any significant effect on the development of cerebral malaria in Plasmodium berghei ANKA-infected CBA/J mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473017      PMCID: PMC1421792     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Killing of Plasmodium falciparum in vitro by nitric oxide derivatives.

Authors:  K A Rockett; M M Awburn; W B Cowden; I A Clark
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

2.  Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.

Authors:  F Y Liew; Y Li; S Millott
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

Review 3.  Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data.

Authors:  G E Grau; P F Piguet; P Vassalli; P H Lambert
Journal:  Immunol Rev       Date:  1989-12       Impact factor: 12.988

4.  Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.

Authors:  I A Clark; N H Hunt; G A Butcher; W B Cowden
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

5.  Serological relationship of tumor necrosis factor-inducing exoantigens of Plasmodium falciparum and Plasmodium vivax.

Authors:  C A Bate; J Taverne; N D Karunaweera; K N Mendis; D Kwiatkowski; J H Playfair
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

6.  Interferon-gamma induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine.

Authors:  P G Kremsner; S Neifer; M F Chaves; R Rudolph; U Bienzle
Journal:  Eur J Immunol       Date:  1992-11       Impact factor: 5.532

7.  TNF inhibits malaria hepatic stages in vitro via synthesis of IL-6.

Authors:  A Nussler; S Pied; J Goma; L Rénia; F Miltgen; G E Grau; D Mazier
Journal:  Int Immunol       Date:  1991-04       Impact factor: 4.823

8.  Pentoxifylline prevents murine cerebral malaria.

Authors:  P G Kremsner; H Grundmann; S Neifer; K Sliwa; G Sahlmüller; B Hegenscheid; U Bienzle
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

9.  IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism.

Authors:  S Mellouk; S J Green; C A Nacy; S L Hoffman
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

10.  Low dosages of interleukin 1 protect mice against lethal cerebral malaria.

Authors:  J H Curfs; J W van der Meer; R W Sauerwein; W M Eling
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

View more
  11 in total

1.  Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale.

Authors:  Michael Hawkes; Robert Opika Opoka; Sophie Namasopo; Christopher Miller; Andrea L Conroy; Lena Serghides; Hani Kim; Nisha Thampi; W Conrad Liles; Chandy C John; Kevin C Kain
Journal:  Med Hypotheses       Date:  2011-07-13       Impact factor: 1.538

2.  Macrophage activation: role of toll-like receptors, nitric oxide, and nuclear factor kappa B.

Authors:  Blase Billack
Journal:  Am J Pharm Educ       Date:  2006-10-15       Impact factor: 2.047

3.  Stimulation of nitric oxide production in macrophages by Babesia bovis.

Authors:  R W Stich; L K Shoda; M Dreewes; B Adler; T W Jungi; W C Brown
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

4.  Group B streptococcus-induced nitric oxide production in murine macrophages is CR3 (CD11b/CD18) dependent.

Authors:  K J Goodrum; L L McCormick; B Schneider
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Levels of circulating nitrate/nitrite and gamma interferon not increased in uncomplicated malaria.

Authors:  D Torre; G Ferrario; A Matteelli; F Speranza; M Giola; A Pugliese; C Cantamessa; G Carosi; G P Fiori
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

Review 6.  The emerging multifaceted roles of nitric oxide.

Authors:  P C Kuo; R A Schroeder
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

Review 7.  Role of nitric oxide in parasitic infections.

Authors:  S L James
Journal:  Microbiol Rev       Date:  1995-12

Review 8.  Experimental cerebral malaria: possible new mechanisms in the TNF-induced microvascular pathology.

Authors:  G E Grau; J N Lou
Journal:  Soz Praventivmed       Date:  1995

9.  Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS-inducing soluble factor.

Authors:  D Ghigo; R Todde; H Ginsburg; C Costamagna; P Gautret; F Bussolino; D Ulliers; G Giribaldi; E Deharo; G Gabrielli; G Pescarmona; A Bosia
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

10.  Modulation of nitric oxide synthase activity in macrophages.

Authors:  P G Jorens; K E Matthys; H Bult
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.